Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell D Cohen

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Gastroenterology|June 25, 2002
Forecast for using metabolite measurements in the dosing of azathioprine or 6-mercaptopurine for IBD patients: "partly cloudy"Russell D Cohen
Gastroenterology|January 31, 2003
The mesalamine wars heat up-enter balsalazideRussell D Cohen
Gastroenterology|March 23, 2002
Cost utility of initial medical management for Crohn's disease perianal fistulaRussell D Cohen
Gastroenterology|June 14, 2003
Infliximab in ulcerative colitis: is there a placebo (effect) in the house?Russell D Cohen
Gastroenterology|January 16, 2004
Infliximab at 5 years--tweaking the recipe for success?Russell D Cohen
Gastroenterology|September 14, 2004
Mesalamine in IBD: multiple hats?Russell D Cohen
Nature Reviews. Gastroenterology & Hepatology|February 6, 2010
The pharmacoeconomics of biologic therapy for IBDRussell D Cohen
Gastroenterology|June 9, 2005
Mycobacterium in Crohn's: something to ruminate about?Russell D Cohen
Gastroenterology|September 7, 2005
Worms, germs and IBD: is it your mother's fault?Russell D Cohen
Gastroenterology & Hepatology|December 13, 2017
Nonmedical Switching of Biosimilars in Patients With Inflammatory Bowel DiseaseRussell D Cohen
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Gastroenterology|June 25, 2002
Forecast for using metabolite measurements in the dosing of azathioprine or 6-mercaptopurine for IBD patients: "partly cloudy"Russell D Cohen
Gastroenterology|January 31, 2003
The mesalamine wars heat up-enter balsalazideRussell D Cohen
Gastroenterology|March 23, 2002
Cost utility of initial medical management for Crohn's disease perianal fistulaRussell D Cohen
Gastroenterology|June 14, 2003
Infliximab in ulcerative colitis: is there a placebo (effect) in the house?Russell D Cohen
Gastroenterology|January 16, 2004
Infliximab at 5 years--tweaking the recipe for success?Russell D Cohen
Gastroenterology|September 14, 2004
Mesalamine in IBD: multiple hats?Russell D Cohen
Nature Reviews. Gastroenterology & Hepatology|February 6, 2010
The pharmacoeconomics of biologic therapy for IBDRussell D Cohen
Gastroenterology|June 9, 2005
Mycobacterium in Crohn's: something to ruminate about?Russell D Cohen
Gastroenterology|September 7, 2005
Worms, germs and IBD: is it your mother's fault?Russell D Cohen
Gastroenterology & Hepatology|December 13, 2017
Nonmedical Switching of Biosimilars in Patients With Inflammatory Bowel DiseaseRussell D Cohen
Pageof 15